Navigation Links
Duke's Ralph Snyderman, M.D. Joins SenGenix as Senior Medical Advisor and Board Member
Date:11/12/2012

DURHAM, N.C., Nov. 12, 2012 /PRNewswire-iReach/ -- SenGenix, a private medical diagnostics company developing protein-based sensor technology for point-of-care testing, announced today that Ralph Snyderman, MD, Chancellor Emeritus of Duke University, has joined the company and will serve as senior medical advisor and a member of the Board of Directors.

Snyderman served as Chancellor for Health Affairs at Duke for 15 years and guided development of the Duke University Health System, one of the first fully integrated academic health systems in the United States.  He also served as its Chief Executive Officer.  Prior to Duke, Snyderman was Senior Vice President, medical research and development, for Genentech. He has earned numerous honors and awards during his career and has served as an advisor and board member for several companies.

"Dr. Snyderman's experience in clinical medicine, biotechnology research and industry is an exceptional asset for SenGenix in commercializing its protein engineering technologies for fast, highly accurate and low cost point-of care testing," said Lawrence Cohen, Chief Executive Officer of SenGenix.  "Dr. Snyderman's global reputation as a health system executive, clinician and researcher will help SenGenix build strong relationships with clinical investigators, physicians and hospital executives as we move forward in product development and into global market introduction."

Founded in 2012, SenGenix will commercialize protein engineering technologies to create a new platform for a menu of the most commonly ordered patient tests that can be performed in any environment -- emergency departments, operating rooms, out-patient surgical centers, physician offices, ambulances, and disaster sites.  SenGenix's technology, which was originally developed at Duke University Medical Center, uses fluorescently responsive sensors printed on test strips to provide easy, highly accurate results in seconds with just a drop of blood.  Unlike other point-of-care testing systems, no expensive sampling cartridges or reader instruments are required with SenGenix technology. 

More information about SenGenix is available at www.sengenix.com.

Media Contact: Lawrence Cohen SenGenix, Inc., 646-354-8361, lcohen@sengenix.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE SenGenix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
2. Keith McCormick Joins Trovagene, Inc. as Head of Commercial Operations
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform
5. David F. Harty Joins Systech International as Vice President
6. Jim DuCharme Joins Prime Therapeutics as Chief Financial Officer
7. Ted Pacha Joins Pinnaclife as President of its Healthcare Distribution Division
8. Rittal Corp. Joins the HP ProActive Insight Architecture Alliance
9. Anthony Creed Joins DDSTUDIO As GM, Experience Design
10. IntelliCell Announces Dr. Arnold I. Caplan Joins Scientific Advisory Board
11. American Society of Hematology joins European Hematology Association, Patient Groups in Issuing International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... , Sept. 18, 2017 EpiVax, ... of bioinformatics and immune engineering, today announced ... influenza A (H7N9) vaccine. ... to seasonal influenza and presents a challenge ... prior exposure to be effective. Using state-of-the-art ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... 2017  ValGenesis Inc., the global leader in ... to announce the appointment of Dr. Ajaz ... of Directors and Chairman of Advisory Board beginning ... companies to manage their entire validation lifecycle process ... this process. Furthermore, ValGenesis VLMS enables rigorous compliance, ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... agency serving communities in the greater Dallas, Miami, and Raleigh regions, is organizing ... fighting to overcome a rare and deadly chromosome abnormality. , After struggling since ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
Breaking Medicine News(10 mins):